West Pharmaceutical Services, Inc. and HealthPrize Technologies Announce Self-Reporting and Barcoding Capabilities for Self-Injection Technology
Experience the interactive Multimedia News Release here: http://www.multivu.com/players/English/7625851-west-pharma-healthprize-tech-collaboration/
Phase 1 of the platform allows for patient self-reporting once the medication has been injected. Phase 2 simplifies the self-reporting process through bar coding or QR coding of self-injection systems, which, when scanned, reports use of the injection system to the HealthPrize patient-engagement system via a secure cloud environment. Bar coding allows for the recording of other medication details, including manufacturing information, pedigree, expiration date, dosage and more.
The final phases of development that are currently in progress are fully integrated injection systems with onboard monitoring and built-in wireless communication capability (integrated connected health) and the connection of legacy, mechanical injectors to the HealthPrize platform via an adaptive attachment (legacy connected health).
In all four phases, data captured over time will afford pharmaceutical companies insight into valuable trends and analytics regarding the actual use of their products.
Medication non-adherence is a leading cause of poor clinical outcomes and increased healthcare costs. Industry analysts estimate that poor medication adherence costs the U.S. healthcare system more than
"West has joined with HealthPrize to develop this platform because we understand the importance of connected health in achieving better patient adherence and outcomes," said
The HealthPrize platform leverages a combination of gamification, behavioral economic concepts, education and rewards to maximize motivational impact. Patients enrolled in HealthPrize programs demonstrate persistently high engagement rates and materially higher adherence rates, nearly 50 percent higher than baseline, on average.
"Our collaboration with West represents a significant leap forward in the ability to engage patients in a meaningful way regarding their injectable treatments, not only in motivating patients to stick with therapy, allowing for improved outcomes, but also in providing pharmaceutical clients with accurate and actionable real-time use data," said HealthPrize CEO and Co-founder
As a leader in drug packaging and delivery systems, West provides solutions for self-injection technologies that provide new options for higher-dose volumes and drug viscosities. West currently offers pharmaceutical customers several unique drug delivery systems, including the SmartDose® electronic wearable injector—the first wearable bolus injector to be studied in a clinical setting, the SelfDose® injector system and the ConfiDose® autoinjector. West is also one of the largest contract manufacturers of injection pens and autoinjectors globally, producing more than 100 million of these devices each year.
HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient-engagement platform provides an innovative approach to addressing the problem of medication nonadherence with an online- and mobile-based program that is fun, educational and rewarding. The HealthPrize system leverages gaming dynamics, behavioral economics and proven concepts from consumer marketing to maximize engagement while also using education to strengthen the intrinsic motivation required for long-term persistence to prescribed medications. For more information, visit www.healthprize.com and follow them on Twitter at @HealthPrize.
SelfDose® and ConfiDose® are registered trademarks of
SmartDose® is a registered trademark of
West seeks partners for its SmartDose®, SelfDose® and ConfiDose® injector technology platforms. These platforms are intended to be used as an integrated system with drug filling and final assembly completed by the pharmaceutical/biotechnology company.
1 The Network For Excellence In Health Innovation. Thinking Outside the Pillbox: A System-wide Approach to Improving Patient Medication Adherence for Chronic Disease.
Corporate Communications, HealthPrize Technologies
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/west-pharmaceutical-services-inc-and-healthprize-technologies-announce-self-reporting-and-barcoding-capabilities-for-self-injection-technology-300144670.html